Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06898996 · ClinicalTrials.gov registry record
FITting Non-invasive Tests in Lynch Syndrome Surveillance
A clinical trial of Colorectal Cancer, sponsored by University of Chicago.
- Recruiting
- Registry status
- 400
- Enrollment target
- 3
- Study locations
NCT06898996: Recruiting study of Colorectal Cancer, sponsored by University of Chicago.
NCT06898996 is a study of Colorectal Cancer that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 400 participants, below the 1,544-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (74% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06898996, a study of Colorectal Cancer, is actively recruiting participants, sponsored by University of Chicago.
- RECRUITING
- Registry status
- 400 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this clinical study is to evaluate the accuracy of the fecal immunochemical test (FIT) in comparison to colonoscopy in patients with Lynch Syndrome (LS) who are undergoing colonoscopy surveillance.
Primary Outcome
Measure specificity of Fecal immunochemical test (FIT) in Lynch Syndrome (LS) patients undergoing colonoscopy surveillance
Conditions Studied
Interventions
- OTHER Fecal immunochemical test
Study Locations (3)
Illinois
- The University of Chicago Medical Center - Chicago
Michigan
- University of Michigan - Ann Arbor
New York
- Columbia University - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2025-07-10 |
| Est. Completion | 2029-07-01 |
What NCT06898996 shows while recruiting
NCT06898996 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 1,544-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (74% lower).
The record links to 1 condition, with Colorectal Cancer appearing as the primary indexed condition, and to 1 intervention - of which Fecal immunochemical test is the first listed.
NCT06898996 reports a single indexed study location in Illinois, Michigan, New York.
Frequently Asked Questions
What is clinical trial NCT06898996 about?
NCT06898996 is a clinical study titled "FITting Non-invasive Tests in Lynch Syndrome Surveillance". The purpose of this clinical study is to evaluate the accuracy of the fecal immunochemical test (FIT) in comparison to colonoscopy in patients with Lynch Syndrome (LS) who are undergoing colonoscopy surveillance.
What is the current status of trial NCT06898996?
This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2025-07-10. Estimated completion is 2029-07-01.
What conditions does trial NCT06898996 study?
This clinical trial studies the following conditions: Colorectal Cancer.
What interventions are being tested in trial NCT06898996?
The interventions under investigation include: Fecal immunochemical test (OTHER).
Who is sponsoring clinical trial NCT06898996?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06898996 being conducted?
This trial has 3 study locations across Illinois, Michigan, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06898996's enrollment target sits among peer trials
400 93rd of 381 higher than 284 of 381 other Colorectal Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colorectal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
RECRUITING · Phase 1
-
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI